Benlysta (belimumab) Coverage and Prior Authorization
Customize your policy alerts
Sign up for Oscar Health Policy PG014 alerts
Get alerted when Policy PG014 changes without checking for updates manually.
Monitor payer policy activity
Medical necessity and prior authorization criteria for intravenous and subcutaneous Benlysta (belimumab) in members aged 5 years and older with active systemic lupus erythematosus or active lupus nephritis receiving standard therapy.
No material clinical or coverage changes in this revision.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.